BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36342412)

  • 1. Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges.
    La Mura V; Bitto N; Tripodi A
    Expert Rev Hematol; 2022 Dec; 15(12):1031-1044. PubMed ID: 36342412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ABNORMALITIES OF HEMOSTASIS IN PATIENTS WITH LIVER CIRRHOSIS].
    Majerović M; Boban A; Premužić M; Radić D; Knežević-Štromar I; Ladić A; Krznarić Ž; Rustemović N; Ostojić R
    Lijec Vjesn; 2016; 138(9-10):272-81. PubMed ID: 30148556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.
    Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI)
    Dig Liver Dis; 2016 May; 48(5):455-467. PubMed ID: 27012444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver cirrhosis--procoagulant stasis].
    Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in cirrhosis: a new paradigm?
    Leonardi F; Maria N; Villa E
    Clin Mol Hepatol; 2017 Mar; 23(1):13-21. PubMed ID: 28288507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis.
    Schepis F; Turco L; Bianchini M; Villa E
    Semin Liver Dis; 2018 Aug; 38(3):215-229. PubMed ID: 30041274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.
    Lisman T; Hernandez-Gea V; Magnusson M; Roberts L; Stanworth S; Thachil J; Tripodi A
    J Thromb Haemost; 2021 Apr; 19(4):1116-1122. PubMed ID: 33792172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic alterations and management of haemostasis in patients with cirrhosis.
    Lisman T; Caldwell SH; Intagliata NM
    J Hepatol; 2022 Jun; 76(6):1291-1305. PubMed ID: 35589251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease.
    Lisman T; Arefaine B; Adelmeijer J; Zamalloa A; Corcoran E; Smith JG; Bernal W; Patel VC
    J Thromb Haemost; 2021 Jan; 19(1):85-95. PubMed ID: 33006808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis.
    Stotts MJ; Lisman T; Intagliata NM
    Semin Thromb Hemost; 2020 Sep; 46(6):716-723. PubMed ID: 32820482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating periprocedural bleeding in patients with cirrhosis.
    Sabate A; Scarlatescu E
    J Thromb Thrombolysis; 2024 Mar; 57(3):531-536. PubMed ID: 38281228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of coagulation abnormalities in liver disease.
    Potze W; Porte RJ; Lisman T
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):103-14. PubMed ID: 24970667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Disease and Hemostatic (Dys)function.
    Tripodi A
    Semin Thromb Hemost; 2015 Jul; 41(5):462-7. PubMed ID: 26080306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the management of coagulation disorders in patients with cirrhosis.
    Aiza-Haddad I; Cisneros-Garza LE; Morales-Gutiérrez O; Malé-Velázquez R; Rizo-Robles MT; Alvarado-Reyes R; Barrientos-Quintanilla LA; Betancourt-Sánchez F; Cerda-Reyes E; Contreras-Omaña R; Dehesa-Violante MB; Flores-García NC; Gómez-Almaguer D; Higuera-de la Tijera MF; Lira-Pedrin MA; Lira-Vera JE; Manzano-Cortés H; Meléndez-Mena DE; Muñoz-Ramírez MR; Pérez-Hernández JL; Ramos-Gómez MV; Sánchez-Ávila JF
    Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):144-162. PubMed ID: 38600006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation Pathways, Hemostasis, and Thrombosis in Liver Failure.
    Intagliata NM; Davis JPE; Caldwell SH
    Semin Respir Crit Care Med; 2018 Oct; 39(5):598-608. PubMed ID: 30485890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hemostatic and thrombotic complications of liver disease.
    McMurry HS; Jou J; Shatzel J
    Eur J Haematol; 2021 Oct; 107(4):383-392. PubMed ID: 34258797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostasis and thrombosis in patients with liver disease: the ups and downs.
    Lisman T; Caldwell SH; Burroughs AK; Northup PG; Senzolo M; Stravitz RT; Tripodi A; Trotter JF; Valla DC; Porte RJ;
    J Hepatol; 2010 Aug; 53(2):362-71. PubMed ID: 20546962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostasis in cirrhosis: Understanding destabilising factors during acute decompensation.
    Zanetto A; Northup P; Roberts L; Senzolo M
    J Hepatol; 2023 May; 78(5):1037-1047. PubMed ID: 36708812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation.
    Fang ZA; Navaei AH; Hensch L; Hui SR; Teruya J
    Semin Thromb Hemost; 2020 Feb; 46(1):62-72. PubMed ID: 31858515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.